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Abstract
BMAL1 and RORα are major regulators of the circadian molecular oscillator.
Since previous work in other cell types has shown cross talk between circadian
rhythm genes and hypoxic signaling, we investigated the role of BMAL1 and RORα in
controlling HIF-1-dependent transcriptional responses in NP cells that exist in the
physiologically hypoxic intervertebral disc. HIF-1-dependent HRE reporter activity
was further promoted by co-transfection with either BMAL1 or RORα. In addition,
stable silencing of BMAL1 or inhibition of RORα activity resulted in decreased HRE
activation. Inhibition of RORα also modulated HIF1α-TAD activity. Interestingly,
immunoprecipitation studies showed no evidence of BMAL1, CLOCK or RORα binding
to HIF-1α in NP cells. Noteworthy, stable silencing of BMAL1 as well as inhibition of
RORα decreased expression of select HIF-1 target genes including VEGF, PFKFB3 and
Eno1. To delineate if BMAL1 plays a role in maintenance of disc health, we studied
the spinal phenotype of BMAL1-null mice. The lumbar discs of null mice evidenced
decreased height, and several parameters associated with vertebral trabecular bone
quality were also affected in nulls. In addition, null animals showed a higher ratio of
cells to matrix in NP tissue and hyperplasia of the annulus fibrosus. Taken together,
our results indicate that BMAL1 and RORα form a regulatory loop in the NP and control
HIF-1 activity without direct interaction. Importantly, activities of these circadian
rhythm molecules may play a role in the adaptation of NP cells to their unique niche.

Introduction

into the disc [1-3]. Several studies have shown that NP
cells respond to changes in osmotic loading by altering
their gene expression and anabolic activities [4-6].
Noteworthy, NP tissue is also completely avascular and
thus cells are adapted to survive in a hypoxic environment
[7-12]. Previous reports clearly show that HIF-1α is a
critical factor for NP cell survival [13] and drives their
glycolytic metabolism [7-9]. Our group has previously
shown that HIF-1α regulation in NP cells is unique.
Particularly, there is robust HIF-1α expression even under
normoxic conditions and its expression is not appreciably
induced under hypoxia [7-12].

The intervertebral disc is a complex tissue that
permits a range of motion between adjacent vertebrae and
accommodates high biomechanical forces in the spine. It
consists of an outer fibrocartilaginous annulus fibrosus
(AF) that encloses a gel-like nucleus pulposus (NP).
Intervertebral discs exhibit diurnal changes in height and
composition. This is caused by high compressive loading
on the disc throughout the day that results in efflux of fluid
from the tissues. At night, under low loading conditions,
osmotic pressure provides a driving force to imbibe fluid
www.impactjournals.com/oncotarget
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BMAL1 (brain and muscle ARNT-like1) and
CLOCK are basic helix-loop-helix-PAS (bHLH-PAS)
transcriptional factors and major components of the
circadian molecular oscillator [14-16]. BMAL1 and
CLOCK form a heterodimer and, by binding to E-box
motifs in promoters, stimulate transcription and translation
of cryptochrome (CRY) and period (PER) family
members. In turn, these genes inhibit BMAL1:CLOCK
activity through formation of repressive complexes [17,
18]. Another important regulatory loop that controls
circadian clock is made up of BMAL1, Retinoic acid
receptor-related Orphan Receptor (ROR)-α and REVERBα, a transcriptional repressor [15, 19, 20]. RORα and
REV-ERBα competitively bind ROR binding sequences
(RORE) in the BMAL1 promoter controlling its levels;
meanwhile, RORα and REV-ERBα transcript levels are
controlled by BMAL1:CLOCK [15, 16, 21]. HIF-α and
HIF-β (ARNT) proteins also belong to the mammalian
bHLH-PAS family [22]. The function of BMAL1 and
RORα in controlling hypoxic HIF-1 activity through
protein-protein interaction has been reported in certain
cell types [23-26] indicating that BMAL1 and RORα may
promote HIF-1α target gene expression. However, whether
a relationship between HIF-1α and circadian regulators
BMAL1 and RORα exists in NP cells is not known.
In this paper, we use in vitro and in vivo approaches
to test the hypotheses that BMAL1 and RORα control
hypoxia and HIF-1- dependent transcriptional responses in
NP cells, and dysregulation of BMAL1 would compromise
disc health. We show here, for the first time, that BMAL1
and RORα modulate HIF-1α transcriptional activity and
influence HIF-1α target genes expression in NP cells.
Moreover, in vivo studies using BMAL1 null mice suggest
that BMAL1 deficiency may alter disc structure and
function. Taken together, our findings suggest that both
BMAL1 and RORα are important regulators of NP cell
function.

RORα transcripts (Figure 1C). To evaluate the effect of
hypoxia on expression of BMAL1 and other ARNT family
members, as well as important circadian rhythm genes,
we measured mRNA and protein expression in NP cells
cultured under hypoxia using qRT-PCR (Figure 1D) and
Western blot analysis (Figure 1E). Our results show that
mRNA expression of ARNT (HIF-1β), ARNT2, BMAL1,
ARNTL2, RORα and CLOCK did not significantly change
under hypoxia (Figure1D). While there was a trend of
increased protein levels of BMAL1 and RORα under
hypoxia, it failed to reach statistical significance (Figure
1F, 1G).

Results

Due to the previously reported contribution of
BMAL1 in controlling HIF-1 and HIF-2 function in
other cell types [23-25, 27], we evaluated mechanisms
by which BMAL1 controlled HIF-1 activity in NP cells.
First, we stably knocked down BMAL1 in rat NP cells
via transduction of lentiviral shRNA. Western blot and
densitometric analysis confirmed that protein levels of
BMAL1 and RORα, a known target of BMAL1, were
lower in BMAL1-silenced NP cells under both hypoxia
and normoxia (Figure 3A -3C). Moreover, activity of
HIF-1α, as measured by HRE reporter, was significantly
suppressed in BMAL1-silenced NP cells (Figure 3D). To
determine if BMAL1 controlled HIF-α-TAD function, we
measured TAD activity following BMAL1 overexpression.
Results clearly showed that overexpression of BMAL1 did
not result in significant change in activity of HIF-1α-CTAD (Figure 3E), HIF-1α-N-TAD (Figure 3F), as well as
HIF-2α-TAD (Figure 3G) regardless of oxygen tension.

BMAL1 synergizes HIF-1 dependent HRE
activity in NP cells
We evaluated the effect of BMAL1 on activity
of a HIF-responsive luciferase reporter (HRE-Luc).
Co-transfection of BMAL1 with a low dose of HIF-1α
promoted HIF-1 mediated activation of the HRE reporter
under both normoxia and hypoxia (Figure 2A and 2B).
A similar increase in activity was seen when ARNT, but
not ARNT2, was co-transfected with HIF-1α (Figure 2A
and 2B). However, addition of BMAL1 or ARNT alone
had little effect on HRE activity. We then measured dosedependency of BMAL1 or ARNT on HRE reporter activity
driven by a sub optimal dose of HIF-1 (Figure 2C-2F).
There was a trend of increasing HRE activity when 50 ng
and 100 ng of BMAL1 or ARNT were co-transfected with
HIF-1α, however a significant change in HRE activity
was noted when BMAL1 (Figure 2C and 2D) and ARNT
(Figure 2E and 2F) were used at 150 ng. All results were
compared with HIF-1α treatment alone.

BMAL1 controls HIF-1 activity without affecting
HIF-α-TAD function

Expression analysis of BMAL1 and other related
factors in NP cells
To investigate expression of BMAL1 in the
intervertebral disc, we stained sections of rat discs with
antibodies against BMAL1 (Figure 1A). The results
show prominent expression of BMAL1 in NP tissue with
many cells evidencing nuclear localization. Western blot
was used to analyze the presence of BMAL1 and RORα
proteins in NP tissues isolated from 3 rats. The expression
of both BMAL1 and RORα was evident in NP tissue
(Figure 1B). In addition, we measured mRNA expression
of BMAL1 and RORα in NP and AF compartments of
the disc. Both tissues indeed expressed BMAL1 and
www.impactjournals.com/oncotarget
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Figure 1: Expression analysis of BMAL1 and other related factors in NP cells. A. Immunohistochemical localization of
BMAL1 in rat intervertebral disc. Sagittal sections of the mature rat intervertebral disc, immunostained with BMAL1 antibody, showed
prominent nuclear expression in NP tissue. B. Western blot analysis of BMAL1 and RORα expression in NP tissues isolated from three rats
showed positive expression for both the proteins. C. qRT-PCR analysis of BMAL-1 and RORα mRNA expression from NP and AF tissues
from rat discs (n=3 animals/group) D. qRT-PCR analysis of BMAL1, RORα, ARNT, ARNT2, ARNTL2 and CLOCK expression in rat NP
cells cultured under hypoxia (1% O2). None of the genes showed significant increase in hypoxia. E. Western blot analysis of BMAL1 and
RORα in NP cells cultured under hypoxia. F., G. Densitometric analysis of multiple blots shown in (E) above. No significant differences
were seen between normoxic and hypoxic levels of BMAL1 and RORα. Data is represented as mean ± SE, n=3, p<0.05.
www.impactjournals.com/oncotarget
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RORα controls HIF-1 transcriptional activity and
TAD function in NP cells

at the highest dose of 150 ng (Figure 4B). Importantly,
regardless of the oxemic tension, RORα alone did not
increase HRE activity at any of the doses tested.
To follow the RORα gain-of-function experiments,
we performed loss-of-function experiments to delineate
effects of RORα inhibition on HIF activity. For this
purpose, we employed a highly specific, cell permeable,
small molecular RORα activity inhibitor ML176 [28, 29].
Treatment of NP cells under both normoxia and hypoxia
with increasing dose of ML176 (2-10 µM) resulted in a
robust decrease in endogenous HIF activity at all doses
as measured by HRE reporter activity (Figure 4C, 4D).
We then measured HIF-α-TAD function in NP cells treated

Since we observed that RORα expression was under
the control of BMAL1 in NP cells, we evaluated the effect
of RORα on HIF activity. When co-transfected under
normoxia, there was a synergistic effect between RORα
(50-150 ng) and HIF-1α on HRE reporter activity as
compared to HIF-1α alone (Figure 4A). On the other hand,
while a trend of increasing activity was seen in hypoxia
at 50 and 100 ng of RORα, a significant synergistic
increase in HIF-1-dependent HRE activity was only noted

Figure 2: BMAL1 synergizes HIF-1 dependent HRE activity in NP cells. A., B. Evaluation of HRE activity in NP cells
transfected with ARNT, ARNT2, and BMAL1 (150 ng/ each) with or without 25 ng of HIF-1α following 24 h culture in hypoxia or
normoxia. Co-transfection of BMAL1 and ARNT but not ARNT2 with HIF-1α significantly increased the activity of HRE compared to
HIF-1α alone. C.-F. Evaluation of HRE activity in NP cells co-transfected with increasing dose of BMAL1(C, D) or ARNT (E, F) with 25
ng of HIF-1α, after 24 h hypoxia and normoxia treatment. The HRE activity showed a significant increase at highest dose of BMAL1 and
ARNT compared to HIF-1 alone. Data is represented as mean ± SE, n=3, * p<0.05.

www.impactjournals.com/oncotarget
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Figure 3: BMAL1 controls HIF-1 activity without affecting HIF-α-TAD function. A. Evaluation of BMAL1 and RORα
expression by Western blot in NP cells stably transduced with lentivirus expressing BMAL1 shRNA. B., C. Densitometric analysis of
multiple blots shown in (A) demonstrated decreased BMAL1 (B) and RORα (C) expression in BMAL1-silenced cells under both normoxia
and hypoxia. D. HRE activity of BMAL1-silenced NP cells is significantly lower than cells transduced with control shRNA. E.-G.
Evaluation of BMAL1 control of HIF-α-TAD function. BMAL1 overexpression had no effects on HIF-1α-C-TAD (E), HIF-1α-N-TAD (F),
as well as HIF-2α-TAD (G) regardless of oxygen tension. Data is represented as mean ± SE, n= 3, * p<0.05.
www.impactjournals.com/oncotarget
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Figure 4: RORα controls HIF transcriptional activity and TAD function in NP cells. A., B. Evaluation of HRE activity in NP
cells transfected with 50-150 ng of RORα with or without 25 ng of HIF-1α, after 24 h hypoxia and normoxia treatment. Under normoxia,
compared to HIF-1α alone, cells co-transfected with RORα and HIF-1α showed a significant increase in HRE activity at all doses, while
under hypoxia this increase was seen at 150 ng of RORα. C., D. Treatment of NP cells with increasing dose of highly specific, small
molecular RORα inhibitor, ML176 (2-10 µM), resulted in decrease in activity of endogenous HIF protein under both normoxia (C) and
hypoxia (D). E.-G. Regulation of HIF-α-TAD function by RORα in NP cells. Treatment with ML176 (10 µM) under both normoxia and
hypoxia resulted in decrease in HIF-1α-C-TAD (E), HIF-1α-N-TAD (F) as well as HIF-2α-TAD (G) activities. Data is represented as mean
± SE, n=3, *p<0.05.
www.impactjournals.com/oncotarget
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BMAL1 knockout mice evidence compromised
disc height and vertebral bone parameters

with ML176. Interestingly, inhibitor treatment resulted in
a decrease in HIF-1α-C-TAD (Figure 4E), HIF-1α-N-TAD
(Figure 4F) as well as HIF-2α-TAD (Figure 4G) activities,
suggesting that RORα may affect HIF-1α transactivation.

Since BMAL1 affected HIF-1 activity in NP cells,
and HIF-1 is necessary for proper functioning of the
intervertebral disc, we wanted to investigate the effects
of BMAL1 loss on the phenotype of post-natal spines.
We analyzed the lumbar disc height of BMAL1 knockout
(KO) mice (10 week old) and their wild type littermates
using micro-computed tomography (µCT) (Figure
7A). Parameters of disc height and vertebral bone were
measured and averaged from the lumbar spine (L1-L5).
The average of three disc height measurements (ventral,
center and dorsal) and disc height index (DHI) were
significantly lower in BMAL1-KO than BMAL1-WT mice
(Figure 7B, 7C), suggesting that in vivo loss of BMAL1
results in thinner discs. We also investigated the effects of
BMAL1 loss on vertebral bone health. BMAL1-KO mice
showed significant decreases in trabecular bone volume
(BV), total volume (TV), bone volume fraction (BV/TV),
trabecular number (Tb.N), and trabecular thickness (Tb.
Th), and a significant increase in trabecular separation (Tb.
Sp) (Figure 7D-7H). However, the connectivity density
(Conn. dens) was not significantly different between WT
and KO animals (Figure 7I). These results indicate that
the vertebral bodies, in addition to the intervertebral discs,
of BMAL1-KO animals are smaller than wild type and
that the bone quality is inferior to the wild type animals.
Noteworthy, loss of BMAL1 has a stronger effect on
discs compared to the vertebral bodies, because the disc
height index is significantly reduced in KO animals
(Figure 7B). In addition, we evaluated the histological
appearance of NP and lamellar structures of the annulus
fibrosus (AF) (Figure 8A-8H). Not surprisingly, NP of
BMAL1 null mice did not phenocopy that of NP-specific
HIF-1α-deficient mice, in that NP cells of BMAL1 null
mice remained viable post-natally [13]. However, analysis
showed that BMAL1-KO animals have lower matrix-tocell ratio (Figure8C, 8D, and 8G), whereas in WT animals
this ratio was higher (Figure 8A, 8B and 8E). Moreover,
AF tissue in BMAL1-KO (Figure 8G, 8H) evidenced
hyperplasia (Figure 8E, 8F) though the fiber orientation
did not show obvious differences between WT and KO.

BMAL1 and RORα do not bind to HIF-1α in NP
cells
Given that BMAL1 and RORα control HIF-1α
activity and function, we investigated the possibility
of direct protein-protein interaction between BMAL1,
RORα and HIF-1α. Surprisingly, immunoprecipitation of
BMAL1 as well as CLOCK in NP cells did not result in
pulldown of HIF-1α (Figure 5A). As expected, BMAL1
evidenced binding with CLOCK and immunoprecipitation
of CLOCK resulted in co-precipitation of BMAL1 (Figure
5A). We also performed immunoprecipiation of HIF-1α to
confirm these findings (Figure 5B). In line with BMAL1
and CLOCK IP results, we were unable to detect coprecipitation of BMAL1, CLOCK or RORα following
pulldown of HIF-1α (Figure 5B). Again, HIF-1α was
seen to associate with HIF-1β/ARNT (Figure 5C). These
findings suggest that BMAL1 and RORα may not bind to
HIF-1α or that the binding is highly transient. In order to
determine if RORα affects HIF-1α levels and translocation
in NP cells, we measured nuclear levels of HIF-1α
following RORα inhibition under hypoxia. Western blot
and corresponding densitometric analysis clearly shows
that treatment of NP cells with ML176 for up to 24 hours
has no apparent effect on nuclear levels of HIF-1α under
hypoxic conditions (Figure 5D, 5E).

BMAL1 and RORα inhibition results in decreased
expression of select HIF-1 target genes
To confirm that suppression of BMAL1 and RORα
affects HIF target gene expression, we measured mRNA
expression of select HIF-1 target genes following stable
silencing of BMAL1 and pharmacological inhibition of
RORα activity. qRT-PCR analysis showed that knockdown
of BMAL1 resulted in a significant decrease in VEGF-A,
enolase 1 (Eno1), PFKFB3 and RORα under both hypoxia
and normoxia (Figure 6A). Similarly, treatment of NP
cells with an RORα inhibitor resulted in decreased mRNA
expression of BMAL1, VEGF, PFKFB3 and Eno1 under
both hypoxia and normoxia (Figure 6B). Interestingly,
however, the expression of other known HIF-1 target
genes, PHD2 and PHD3 (not shown), remained unaffected
in BMAL1 silenced and ML176 treated NP cells.

www.impactjournals.com/oncotarget

Discussion
BMAL1 (brain and muscle ARNT-like1), CLOCK
and HIF-α are basic helix-loop-helix-PAS (bHLHPAS) transcriptional factors that share similarities in
their bHLH and PAS dimerization domains [22, 30].
Canonically, BMAL1 acts through heterodimerization
with CLOCK, and binding to E-box motifs -CACGTG
in target gene promoters [17, 18], while HIF-α binds
to its partner HIF-1β/ARNT to transcribe targets that
allow cellular adaptation to hypoxia. A few reports have
23062
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Figure 5: BMAL1 and RORα do not bind to HIF-1α in NP cells. A. Immunoprecipitation (IP) of BMAL1 and CLOCK from
NP cells cultured under normoxia or hypoxia for 24 h followed by Western blot analysis using anti-HIF-1α, anti-BMAL1 and anti-CLOCK
antibodies. BMAL1 bound to CLOCK, but neither BMAL1 nor CLOCK bound to HIF-1α irrespective of oxygen tension. Preimmune
rabbit IgG was used as a negative control for IP assays. B. Pulldown of HIF-1α did not show co-precipitation of BMAL1, CLOCK, or
RORα. HC: heavy chain of IgG, nsp: non-specific (C) Pulldown of HIF-1α showed co- precipitation of HIF-1β/ARNT, association was
higher under hypoxia. D., E. Treatment of NP cells with RORα inhibitor, ML-176 (10 µM), showed no effect on nuclear levels of HIF-1α.
Densitometric analysis shown in (E) was performed on blots from 3 independent experiments, Data is represented as mean ± SE, * p < 0.05.
www.impactjournals.com/oncotarget
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described a non-canonical function of BMAL1, dimerizing
with HIF-1α under hypoxia, and activating transcription
through binding to HRE motifs [23-25]. However, this
hypoxia and HIF-dependent role of BMAL1 seems to
be cell-type specific [31]. Since HIF-1α is necessary for
NP cell survival in the hypoxic niche [13], we sought
to investigate the potential role of the circadian master
regulator BMAL1 in controlling HIF-1 function in the
intervertebral disc.
In our findings, BMAL1 overexpression alone did
not change HRE activity. Noteworthy, co-transfection of
BMAL1 with HIF-1α increased HRE activity compared
with HIF-1α expression alone. This suggests that BMAL1
in NP cells can cooperate with HIF-1α to activate HRE
mediated transcription. Interestingly, our evaluation of
HIF-TAD domains indicated that BMAL1 overexpression
did not modulate recruitment of other co-factors by HIFs.
Surprisingly, immunoprecipitation results showed neither
BMAL1 nor CLOCK bound to HIF-1α, suggesting
either lack of binding or a very transient nature of their
interaction. These results are also in agreement with a
report by Ghorbrl et al. demonstrating that BMAL1,
CLOCK and HIF-1α cooperatively affected transcriptional
regulation of vasopressin without heterodimerization
[25]. It is therefore not unreasonable to assume that in NP
cells BMAL1 activates HIF-1α function without direct

dimerization.
To further assess the function of the BMAL1HIF axis in NP, we evaluated HIF activity in BMAL1silenced NP cells. Downregulation of HRE activity in
BMAL1-silenced NP cells demonstrates that BMAL1
controls HIF-1α activity. Importantly, when BMAL1
expression was suppressed, VEGF-A, Eno1 and PFKFB3
mRNA expression were downregulated. These three HIF1 targets have been reported to contain E-box motif in
their promoters and are sensitive to BMAL1 mediated
regulation. A direct BMAL1 interaction with the E-Box
has also been demonstrated in the case of VEGF-A
promoter [32-35]. Noteworthy, the relationship between
E-box motif and HRE sequence has been reported;
although HIF-1 binding does not usually occur at the
palindromic E-box, high percentage of rat, mouse and
human gene promoters with functionally validated
HREs overlap with predicted E-boxes [36-38]. These
reports implicate that binding of BMAL1:CLOCK to the
E-box sequences in gene promoters may affect HIF-1α
recruitment and activity at nearby or overlapping HRE
sites, effectively regulating its target gene expression.
Furthermore, we investigated the role of RORα
in NP cells. It has been well known that RORα is an
important regulator of BMAL1, and they regulate each
other’s expression via a feedback loop [15, 19, 20]. Our

Figure 6: BMAL1 and RORα inhibition results in decreased expression of select HIF-1 target genes. A.-B. qRT-PCR
analysis of mRNA expression of select HIF-1 target genes following stable silencing of BMAL1 (A) or pharmacological inhibition of
RORα activity by ML176 (10 µM) treatment. Knockdown of BMAL1 resulted in significant decrease in VEGF-A, enolase 1 (Eno1),
PFKFB3 as well as RORα under both normoxia and hypoxia. B. NP cells treated with RORα inhibitor showed decreased mRNA expression
of BMAL1, VEGF, PFKFB3 and Eno1. Expression of PHD2, another known HIF-1 target gene, remained unaffected in BMAL1 silenced
and ML176 treated NP cells. Data is represented as mean ± SE. n=5, *p<0.1.
www.impactjournals.com/oncotarget
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Figure 7: BMAL1 knockout mice (KO) evidence compromised disc height and vertebral bone health. A. Representative
µCT scans of lumbar spine (L1-L5) of a wild type and a KO littermate (10 week). Left panels show a coronal cut-plane through 3D
reconstructions of the full lumbar segments of a WT and BMAL1 KO animal, showing changes in DHI. The right panels show a
representative 3D reconstruction of ROI chosen for the bone trabecular morphometric analysis of each vertebral body showing changes in
trabecular bone. The ROI contour only the outer boundary of the trabecular bone, excluding the cortical bone. B., C. The average of three
disc height measurements (ventral, center and dorsal) (B) and disc height index (DHI) (C) were significantly lower in BMAL1-KO mice.
D.-H. BMAL1 KO animals showed significant decreases in trabecular bone volume (BV) and total volume (TV) (D), bone volume fraction
(BV/TV) (E), trabecular number (Tb.N) (F), and trabecular thickness (Tb. Th) (G), and a significant increase in trabecular separation (Tb.
Sp) (H). I. Connectivity density (Conn. dens) was unaffected in KO animals. Data is represented as mean ± SE. n = 4 animals/genotype, 5
lumber vertebrae were measured/animal, *p<0.05.
www.impactjournals.com/oncotarget
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Figure 8: BMAL1 null mice shows altered disc morphology. A.-D. Representative images of H&E and alcian blue staining of

sagittal sections of lumbar disc from WT and KO mice. Compared to that of WT animals (A, B) NP tissue in null animals show decreased
accumulation of matrix (lower matrix-to-cell ratio) (C, D), Scale bars: A, C: 50 μm, B, D: 10 μm. Disc height on images is outlined with
dotted line. E.-H. Representative image of Picosirius red staining of WT and KO under bright field (E, G) and polarized light (F, H).
Annulus fibrosus (AF) tissue in KO animals showed hyperplasia and increased thickening (white arrow). Scale bars: 100 μm.
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results that show decreased BMAL1 mRNA in RORα
inhibitor treated cells and suppressed RORα protein and
mRNA in BMAL1-silenced NP cells clearly support
an inter-relationship between BMAL1 and RORα.
Importantly, similar to BMAL1, RORα promoted HIF-1αdependent HRE activity under hypoxia. A previous study
with NIH3T3 cells reported that the DNA-binding domain
of RORα directly interacted with the inhibitory domain
of HIF-1α, increasing its stability [26]. However, our
immunoprecipitation experiments did not support an overt
RORα-HIF-1α interaction in NP cells if any, suggesting
a possible cell-type specific characteristic. Together these
results indicate that RORα influences HIF-1α activity
plausibly without a direct protein-protein interaction
between them. Interestingly, inhibition of RORα activity
by ML176 resulted in a decreased HIF-1α-TAD activity
as well as mRNA expression of VEGF-A, PFKFB3, Eno1,
and BMAL1. These findings indicate that RORα may
affect HIF-1 activity and target gene expression in NP cells
through modulating co-factor recruitment. Since BMAL1
and RORα coregulate each other’s expression, they are
likely to influence HIF-1α in a cooperative fashion.
Our studies show for the first time that BMAL1
and RORα, two important molecules in circadian rhythm
machinery, are involved in the regulation of HIF-1α
transcriptional function in NP cells through an indirect
mechanism. In fact, the evaluation of BMAL1 KO mice
demonstrated that BMAL1 is important for maintenance of
discs and vertebral health. Both disc height and vertebral
volume were smaller in BMAL1 KO mice compared to
WT. Importantly, DHI of BMAL1 KO was also decreased,
indicating a more crucial role for BMAL1 in maintenance
of disc health compared to vertebral bodies. These results
complimented the studies that showed early aging in other
tissues from BMAL1 deficient mice [39]. It was also not
surprising to see that NP phenotype of BMAL1 null mice
did not phenocopy that of NP-specific HIF-1α-deficient
mice, where NP cells die postnatally [13]. Since BMAL1
co-regulated only a subset of HIF-1 target genes in NP
cells, and because it is one of many regulators of HIF-1α
function, lack of NP cell death is to be expected. Thus,
this observation suggests that BMAL1 is dispensable
for survival of notochordal NP. Still, histological studies
of BMAL1 null mice showed decreased matrix-to-cell
ratio in post natal NP. This implicated a possible delay in
maturation and decreased secretion of proteoglycan rich
matrix by notochordal cells that give rise to adult NP [40].
Whether this NP phenotype is due to modulation of HIF1 transcriptional activity controlling cell proliferation and
differentiation in NP cells [41] or due to BMAL1 function
independent of HIF-1 remains to be seen. In contrast to
the effects on NP compartment, AF tissue in BMAL1 null
mice evidenced hyperplasia, suggesting that the effects
of BMAL1 deletion are tissue specific. Relevant to this
discussion, in a recent study Numaguchi et al. showed
that rats exposed to passive cigarette smoking for 8 weeks
www.impactjournals.com/oncotarget

showed a significant alteration in many clock-related
genes in both AF/CEP and NP tissues of the intervertebral
disc [42]. Importantly, in discs these clock genes showed
expression patterns consistent with a circadian rhythm,
with several genes including Per1, Per2, Cry1, Nr1d1
and Npas2, clearly evidencing a phase shift of anywhere
between 3 to 9 h due to smoking. Significantly, BMAL1
and another clock gene, Dbp, demonstrated complete
abrogation of oscillation in the NP in smoke exposed
animals [42]. Since smoking is considered an important
risk factor for disc degeneration, and has been shown
to promote NP cell dysfunction and matrix deposition
[43,44], it is plausible that some of the pathological
changes seen in disc in these smoke exposed animals may
be attributed to altered clock gene activity. Taken together,
our results suggest that BMAL1 and RORα regulate HIF-1
activity in NP cells and play an important role in overall
adaptation of NP cells to their hypoxic niche, and their
dysregulation affects normal tissue homeostasis and
function. Further investigations on the contribution of
BMAL1 in progression of disc degeneration are under
way.

Materials and methods
Plasmids and reagents
Plasmids were kindly provided by Dr. Taku Saito,
University of Tokyo, Japan (HA-ARNT, -ARNT2, and
-BMAL1) [27], Dr. Ren Xu, University of Kentucky,
Lexington (pCDH1-RORα-flag) [45], and Dr. Vijay
K. Yechoor, Baylor College of Medicine, Houston
(Lentiviral shBMAL1) [46]. HIF-1α-C-TAD, aa740826; HIF-1α-N-TAD, aa 530-778; and HIF-2α-TAD,
aa 819–870 were provided by Dr. Nianli Sang, Drexel
University, Philadelphia, PA. pFR-Luc (Stratagene)
reporter contains the firefly luciferase gene. psPAX2 (#
12260) and pMD2G (#12259) developed by Dr. Didier
Trono and HRE-Luc (#26731) were obtained from
Addgene’s repository. For internal transfection control,
vector pRL-TK (Promega) containing Renilla reniformis
luciferase gene was used. RORα inverse agonist ML176
was purchased from Cayman Chemical (Michigan). This
selective inverse agonist competitively blocks the binding
of 25-hydroxycholesterol to the ligand-binding domain
of RORα and inhibits transactivation function. Spines of
BMAL1-/- mice (9-10 weeks old) were kindly provided
by Dr. Vijay Yechoor [46]. These mice were generated
by breeding of Bmal1+/- on a C57Bl/6J background and
maintained under 12:12 Light/Dark cycles, with lights on
at 7 AM—Zeitgeber Time 0 (ZT-0) under ad lib access to
food and water.
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Isolation of NP cells, cell treatments and hypoxic
culture

of BMAL1, and activity measured following normoxic or
hypoxic culture for 24 h. TAD activity was also measured
by treating cells with RORα inhibitor ML176 (10 µM)
for 24 h. In all experiments, plasmids were premixed
with the transfection reagent, LipofectAMINE2000
(Invitrogen). The next day, cells were harvested and
Dual-Luciferase™ reporter assay system (Promega) was
used for measurements of firefly and Renilla luciferase
activities using a luminometer (TD-20/20, Turner Designs
CA).

Rat (Sprague-Dawley, 10 week old) or mouse
(C57Bl/6J, 10 week old) NP cells were isolated using
a method reported earlier by Risbud et al. [8]. Animals
were maintained under 12:12 Light/Dark cycles with ad
lib access to food and water. Cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) and 10%
fetal bovine serum (FBS) supplemented with antibiotics,
and cultured in a Hypoxia Work Station (Invivo2 300,
Ruskinn, UK) with a mixture of 1% O2, 5% CO2 and 94%
N2 for 8-72 h.

Protein Extraction, nuclear fractionation and
Western blotting and Immunoprecipitation

RNA isolation and Real Time RT-PCR Analysis

Cells were immediately placed on ice and washed
with ice-cold PBS. All wash buffers and the final
resuspension buffer included 1x protease inhibitor mixture
(GE Healthcare), NaCl (150 μM), β-glycerophosphate
(62.5 mM), DTT (0.1 μM), NaF (5 mM), and Na3VO4
(200 μM). When needed, CelLytic NuCLEAR extraction
kit (Sigma Aldrich) was used to generate nuclear proteins.
Immunoprecipitation was performed using Protein A/G
PLUS-Agarose beads (SantaCruz) following standard
protocol. Proteins were resolved on 8–12% SDSpolyacrylamide gels and transferred by electroblotting
to PVDF membranes (Bio-Rad). The membranes were
blocked with 5% nonfat dry milk in TBST (50 mM Tris
pH 7.6 with 0.1% Tween 20) and incubated overnight
at 4°C in 5% nonfatdry milk in TBST with antibody.
Immunolabeling was detected using the ECL reagent
(Amersham Biosciences). Relative expression levels
were determined by quantitative densitometric analysis
using one-dimensional image analysis software (GE
Healthsciences). Antibodies used were anti-BMAL1
(#14020, Cell Signaling), anti-CLOCK (#5157, Cell
Signaling; #3517, Abcam), anti-RORα (#NBP1-52813,
Novus), anti-HIF-1α (#MAB1536, R&D Systems;
#ab2185, Abcam), anti-HIF-1β/ARNT (#5537, Cell
Signaling), anti-GAPDH (#NB300-221SS, Novus) and
anti-Lamin A/C (#2032, Cell Signaling).

For analysis of BMAL1 and RORa in disc
compartments, NP and AF tissues were isolated from
adult Sprague-Dawley rats and immediately incubated in
RNAlater (Thermofisher, AM7021) at 4oC. NP tissue was
transferred to lysis buffer and homogenized with a Pellet
Pestle Motor (Sigma Aldrich, Z359971) for 1 minute. AF
tissue was frozen in liquid nitrogen and pulverized with
a BioPulverizer (BioSpec). Pulverized AF tissue was
transferred to TRIzol Reagent (Lifetechnologies) and
DNA-RNA was isolated according to Lifetechnologies
protocol and a DNA-free kit (Lifetechnologies). Total
RNA was extracted from NP cells and NP tissue lysates
using RNAeasy mini columns (Qiagen). Before elution
from the column, RNA was treated with RNase free
DNase I (Qiagen). The purified, DNA-free RNA was
converted to cDNA using EcoDry™ Premix (Clontech).
Template cDNA and gene-specific primers were added to
Power SYBR Green master mix (Applied Biosystems) and
mRNA expression was quantified using the Step One Plus
Real-time PCR System (Applied Biosystems). HPRT1 was
used to normalize gene expression. Melting curves were
analyzed to verify the specificity of the RT-PCR and the
absence of primer dimer formation.

Transfections and dual luciferase assay

Lentiviral production and transduction

Cells were transferred to 48-well plates (2×104 cells/
well) one day pre-transfection. Cells were transfected
with 175 ng HRE luciferase reporter with or without 25
ng of HA-HIF-1α and 0-150 ng of ARNT or ARNT2, or
BMAL1 or RORα or empty backbone plasmids and 150
ng pRL-Tk, and reporter activities measured following
culture under normoxia or hypoxia for 24 h. To measure
effect of RORα inhibition on HIF-1 activity, cells were
transfected with HRE reporter and activity measure after
treatment with 0-10 μM ML176 for 24 h. To measure
effect on HIF transactivation, cells were cotransfected with
HIF-α-TAD plasmids (25 ng each) with or without 150 ng
www.impactjournals.com/oncotarget

HEK 293T cells were seeded in 10-cm plates (5×106
cells/plate) in DMEM with 10% heat-inactivated FBS one
day before transfection. Cells were transfected with 9 μg
of shBMAL1 or pGIPZ plasmids along with 6 μg psPAX2
and 3 μg pMD2G using Calcium phosphate transfection
kit (CalPhos, Clontech). After 16 h, transfection medium
were removed and replaced with DMEM with 10% heatinactivated FBS. Lentiviral particles were harvested at
48 and 60 h post-transfection. NP cells in 10 cm plates
were transduced with 8 ml of medium containing viral
particles with 6 μg/ml Polybrene. After 24 h, viral media
was removed and replaced with DMEM with 10% FBS.
23068

Oncotarget

Statistical analysis

5 days after viral transduction, cells were used for protein
and mRNA evaluation.

All measurements were performed in triplicate, and
data are presented as mean ± S.E. Differences between
groups were analyzed by the Student’s t test and one-way
ANOVA; p<0.05.

Micro-computed tomography analysis of BMAL1
knockout mouse spine
Micro-computed tomography scans (MicroCT40,
SCANCO Medical, Switzerland) were performed
on spines of BMAL1-/- and wild type mice (n=4/
genotype) fixed with 4% PFA. Segments of lumbar spine
incorporating L1-L5 were scanned with an energy of
70 kVp, a current of 114 mA, and a 200-ms integration
time producing a resolution of 16 mm3 voxel size. The
cross sectional scans were analyzed to quantify changes
in trabecular bone microarchitecture by first drawing
regions of interest (ROI) that contour the outer boundary
of the trabecular bone, excluding the cortical bone.
The ROI were then compiled into 3D data sets using a
Gaussian filter (σ = 1.0, support = 1) to reduce noise,
and converted to binary images with a fixed grey-scale
threshold of 200. The 3D data sets were assessed for
the following parameters using software supplied by the
system manufacturer: trabecular bone volume (BV), total
volume (TV), bone volume ratio (BV/TV), trabecular
thickness (Tb. Th), trabecular number (Tb.N) trabecular
separation (Tb. Sp), connectivity density (Conn.dens.)
and disc height between each vertebra. Disc height was
determined by measurements made in three areas of the
disc space: on the ventral, central and dorsal side, and
an average of these values. Disc height index (DHI) was
calculated by dividing average disc height by height of
adjacent vertebral bodies. All heights were calculated by
multiplying the number of cross sectional slices spanning
the structure of interest by the known thickness of each
slice.
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